Clinical Trial Update: Impact of Chemokine Receptor 5 (CCR5) Inhibition on Sarcoidosis Immunophenotypes [NA]

View source ↗

Summary

Results from a terminated trial evaluating CCR5 inhibition in sarcoidosis immunophenotypes have been posted. The study investigated immunophenotypic changes in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcoidosis

Snippet

Sponsor: Kevin F. Gibson | Conditions: Sarcoidosis | NA | Status: TERMINATED | Results posted: 2017-07-18